Imoxtreat-P Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Prednisolone 1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammation, such as conjunctivitis, keratitis, and postoperative ocular inflammation. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Prednisolone acts by suppressing the inflammatory response, reducing ocular redness, swelling, and discomfort. Imoxtreat-P Eye Drop provides a dual therapeutic approach by simultaneously addressing infection and inflammation, promoting faster recovery and symptom relief. It is intended for topical ophthalmic use and should be administered as directed by a healthcare professional. Caution is advised in patients with known hypersensitivity to fluoroquinolones or corticosteroids, and prolonged use should be avoided to minimize the risk of steroid-induced ocular side effects such as increased intraocular pressure or cataract formation. Proper hygiene should be maintained to prevent contamination of the dropper tip. Imoxtreat-P Eye Drop is contraindicated in viral, fungal, or mycobacterial eye infections unless combined with appropriate antimicrobial therapy.